Eton Pharmaceuticals (ETON) Net Cash Flow (2018 - 2025)
Eton Pharmaceuticals (ETON) posted Net Cash Flow of -$11.2 million for Q4 2025, down 195.21% sequentially from $11.7 million in Q3 2025, and down 109.93% YoY from $112.5 million in Q4 2024.
Eton Pharmaceuticals (ETON) Net Cash Flow (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported Net Cash Flow for 8 years, with the latest figure at -$11.2 million in Q4 2025.
- Quarterly Net Cash Flow fell 109.93% year-over-year to -$11.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.0 million (up 270.58% YoY) and the FY2025 annual result came in at $11.0 million, up 270.58% from the prior year.
- Net Cash Flow slipped to -$11.2 million in Q4 2025 per ETON's latest filing, from $11.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $11.7 million in Q3 2025 and troughed at -$11.2 million in Q4 2025.
- A 5-year average of $197500.0 and a median of $663500.0 in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Net Cash Flow surged 22812.5% in 2022, then tumbled 680.79% in 2024.
- Over 5 years, Net Cash Flow stood at -$8.3 million in 2021, then surged by 135.25% to $2.9 million in 2022, then sank by 123.3% to -$682000.0 in 2023, then sank by 680.79% to -$5.3 million in 2024, then plunged by 109.93% to -$11.2 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$11.2 million, $11.7 million, and $8.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.66 Bn | 1.63 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.18 Mn |
| Dec 31, 2025 | -11.18 Mn |
| Sep 30, 2025 | 11.74 Mn |
| Sep 30, 2025 | 11.74 Mn |
| Jun 30, 2025 | 7.96 Mn |
| Jun 30, 2025 | 7.96 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | -5.33 Mn |
| Dec 31, 2024 | -5.33 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | -4.73 Mn |
| Mar 31, 2024 | -4.73 Mn |
| Dec 31, 2023 | -682,000.00 |
| Dec 31, 2023 | -682,000.00 |
| Sep 30, 2023 | 504,000.00 |
| Sep 30, 2023 | 504,000.00 |